Supplier profile
Abacus Medicine A/S
Every public-sector award we hold for this supplier, across Belgium, Germany, Denmark, Spain, Finland, the UK, Luxembourg and Sweden, from 25 Mar 2013 to 23 Sept 2026.
Awards won
375
all time
Attributed value
€219k + DKK 146.6m
343 shared, unvalued
Buyers
28
public bodies
Active
2013–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 177 | not attributable |
| Amgros I/S | 142 | DKK 146.6m |
| IKK classic | 13 | €219k |
| PBMG eG | 5 | €1 |
| Techniker Krankenkasse | 4 | €1 |
| AOK Nordost – Die Gesundheitskasse | 3 | not attributable |
| AOK Plus – Die Gesundheitskasse für Sachsen und Thüringen | 3 | not attributable |
| Fédération des hôpitaux luxembourgeois (FHL), association sans but lucratif | 3 | not attributable |
| AOK Nordwest – Die Gesundheitskasse | 2 | not attributable |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen | 2 | not attributable |
What they win
Awards
Showing 76–100 of 375 awards we hold
- Denmark – Pharmaceutical products – Amgros 2025 1.1163.a ↗Amgros I/Sshared awardawarded 29 Nov 2024
- Rabattvertrag gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Abacus Medicine A/S zu Zepatier, ATC-Code: J 05 A P 54, Vertragslaufzeit: 01.01.2025 bis 31.12.2026 ↗IKK classic€1awarded 29 Nov 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.709.a ↗Amgros I/Sshared awardawarded 26 Nov 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1208.b ↗Amgros I/Sshared awardawarded 25 Nov 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1201.a ↗Amgros I/Sshared awardawarded 30 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1303.b ↗Amgros I/Sshared awardawarded 30 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1305.a ↗Amgros I/Sshared awardawarded 25 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1200.a ↗Amgros I/Sshared awardawarded 25 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1203.a ↗Amgros I/Sshared awardawarded 23 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1306.b ↗Amgros I/Sshared awardawarded 23 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 2.3.b ↗Amgros I/Sshared awardawarded 18 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.203.b ↗Amgros I/Sshared awardawarded 17 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.202.a ↗Amgros I/Sshared awardawarded 17 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.550.b ↗Amgros I/Sshared awardawarded 16 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Faricimab, ATC S01LA09 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AC07 für die Zeit 01.10.2024 - 30.11.2025 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Allergenextrakt aus Wiesenlieschgras, Ruchgras, etc. (ausschl. SUT), ATC V01AA02 f. d. Z. 01.10.24-30.09.26 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AC07 für die Zeit 01.10.2024 - 30.11.2025 ↗DAK-Gesundheitshared awardawarded 1 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2024 - 31.08.2026 ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Natalizumab (ausschl. in der Dafo. Injektionslösung, ATC L04AA23 für die Zeit 01.09.24 - 31.08.26 ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Emtricitabin + Rilpivirin + Tenofovir disoproxil fumarat, ATC J05AR08 f. d. Z. 01.09.24 - 31.08.26 ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02 für die Zeit 01.09.2024 - 31.08.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Abatacept, ATC L04AA24 für die Zeit 01.09.2024 - 31.08.2026 ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.